These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26743722)

  • 21. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.
    Semenkovich K; Brown ME; Svrakic DM; Lustman PJ
    Drugs; 2015 Apr; 75(6):577-87. PubMed ID: 25851098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-specific impact of major depressive disorder on 12-year change in glycaemic status: Results from a nationwide cohort study of adults without diabetes in Germany.
    Nübel J; Truthmann J; Heidemann C; Du Y; Paprott R; Hapke U; Kruse J; Scheidt-Nave C; Baumert J
    Diabet Med; 2022 Mar; 39(3):e14767. PubMed ID: 34890066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of antidepressant medication use in the Canadian diabetes population.
    Ivanova A; Nitka D; Schmitz N
    Soc Psychiatry Psychiatr Epidemiol; 2010 Sep; 45(9):911-9. PubMed ID: 19730761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.
    Aikens JE; Piette JD
    Diabet Med; 2013 Mar; 30(3):338-44. PubMed ID: 23075262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes.
    Bogner HR; de Vries HF; O'Donnell AJ; Morales KH
    Am J Manag Care; 2013 Mar; 19(3):e85-92. PubMed ID: 23534947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.
    Han J; Yu H; Tu Y; Pang J; Liu F; Bao Y; Yang W; Jia W
    Diabet Med; 2017 Apr; 34(4):490-499. PubMed ID: 27151271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.
    Cook MN; Girman CJ; Stein PP; Alexander CM
    Diabet Med; 2007 Apr; 24(4):350-8. PubMed ID: 17335466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national Electronic Health Record (EHR) network.
    Gill JM; Chen YX; Lieberman MI
    Int J Psychiatry Med; 2008; 38(2):203-15. PubMed ID: 18724571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of random plasma glucose for assessment of glycaemic control in type 2 diabetes mellitus.
    Ain Q; Latif A; Jaffar SR; Ijaz A
    J Pak Med Assoc; 2017 Sep; 67(9):1353-1356. PubMed ID: 28924273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of glycaemic control in Australian primary care (NEFRON 8).
    Macisaac RJ; Jerums G; Weekes AJ; Thomas MC
    Intern Med J; 2009 Aug; 39(8):512-8. PubMed ID: 19220533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial.
    Paile-Hyvärinen M; Wahlbeck K; Eriksson JG
    BMC Fam Pract; 2007 Jun; 8():34. PubMed ID: 17570858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.
    Katon WJ; Von Korff M; Lin EH; Simon G; Ludman E; Russo J; Ciechanowski P; Walker E; Bush T
    Arch Gen Psychiatry; 2004 Oct; 61(10):1042-9. PubMed ID: 15466678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates of glycaemic deterioration in a real-world population with type 2 diabetes.
    Donnelly LA; Zhou K; Doney ASF; Jennison C; Franks PW; Pearson ER
    Diabetologia; 2018 Mar; 61(3):607-615. PubMed ID: 29260253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes.
    Lavikainen P; Aarnio E; Jalkanen K; Tirkkonen H; Rautiainen P; Laatikainen T; Martikainen J
    BMC Health Serv Res; 2020 Nov; 20(1):1095. PubMed ID: 33246453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
    Rubin RR; Peyrot M; Gaussoin SA; Espeland MA; Williamson D; Faulconbridge LF; Wadden TA; Ewing L; Safford M; Evans-Hudnall G; Wing RR; Knowler WC;
    Diabetes Care; 2013 May; 36(5):1088-94. PubMed ID: 23359362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.